Abstract: These All pig-producing countries from around the world report the presence of Postweaning multisystemic wasting syndrome (PMWS.) In America, PCV2 has been recognized in Canada, United States and Brazil. Knowledge concerning the genetic sequences of PMWS has been very important. In Mexico, there is no report describing the genetic sequences and variations of the PCV2 virus present around the country. For this reason, the main objective was to describe the homology and genetic sequences of the PCV2 virus obtained from different regions of Mexico. The results show that in Mexico are present both subgenotypes \"a\" and \"b\" of this virus and the homologies are from 89 to 99%. Regarding with the aminoacid sequence, three major heterogenic regions were present in the position 59-91, 123–136 and 185–210. This study presents the results of the first genetic characterization of PCV2 in production herds from Mexico.
Abstract: The main objective of this study was to demonstrate that differentiation of infected and vaccinated animals (DIVA) strategy using different ELISA tests is possible when a subunit vaccine (Haemagglutinin protein) is used to prevent Avian influenza. Special emphasis was placed on the differentiation in the serological response to different components of the AIV (Nucleoprotein, Neuraminidase, Haemagglutinin, Nucleocapsid) between chickens that were vaccinated with a whole virus kill vaccine and recombinant vaccine. Furthermore, the potential use of this DIVA strategy using ELISA assays to detect Neuraminidase 1 (N1) was analyzed as strategy in countries where the field virus is H5N1 and the vaccine used is formulated with H5N2. Detection of AIV-s antibodies to any component in serum was negative for all animals on the study days 0-13. At study day 14 the titers of antibodies against Nucleoprotein (NP) and Nucleocapsid (NC) rose in the experimental groups vaccinated with Volvac® AI KV and were negatives during all the trial in the experimental groups vaccinated with a subunit H5; significant statistically differences were observed between these groups (p < 0.05). The seroconversion either Haemagglutinin or Neuraminidase was evident after 21 days post-vaccination in the experimental groups vaccinated with the respective viral fraction. Regarding the main aim of this study and according with the results that were obtained, use a combination of different ELISA test as a DIVA strategy is feasible when the vaccination is carry out with a subunit H5 vaccine. Also is possible to use the ELISA kit to detect Neuraminidase (either N1 or N2) as a DIVA concept in countries where H5N1 is present and the vaccination programs are done with H5N2 vaccine.